IFPA

What is it like to grow up with a visible condition like psoriasis that everyone can see, but few can truly understand?

For many young people living with psoriasis, the biggest challenges are often invisible: anxiety, isolation, shame, self-doubt, and the feeling of being judged before being known.

Read the article, originally published in Sweden's Svenska Dagbladet, where four young people share their personal experiences of living with psoriasis:

💜 Oscar talks about overcoming fear of others' opinions and following his dreams with confidence.

💜 Anita shares the reality of good days and bad days, and how running helps her cope with stress and flare-ups.

💜 Samvel reflects on how psoriasis affected his mental health but also made him more empathetic and resilient.

💜 Christine describes living with psoriasis symptoms that others cannot see, and why greater awareness of psoriasis matters.

In our campaign this year, we are putting young people at the center of the conversation with the theme .

Their stories remind us that psoriasis is more than what appears on the surface, and that empathy and inclusion can make a real difference.

is a call to see the whole person, not just the visible symptoms, understand their pain and embrace them for who they are.
📖🔗 Read the article:
https://eu1.hubs.ly/H0wH3G20

How much are psoriasis and psoriatic arthritis really costing our health systems and economies?

Our new research, published in Dermatology and Therapy, found that cardiovascular disease, diabetes, obesity and depression, associated with psoriasis and psoriatic arthritis, generate substantial healthcare costs and productivity losses, amounting to billions over time.

The study estimates that these conditions generate:
🔸USD 5.2 billion every year and USD 153 billion over a lifetime in the United States
🔸EUR 55 million every year and EUR 1.4 billion over a lifetime in Denmark
🔸USD 22 million every year and USD 673 million over a lifetime in Vietnam

The good news? Earlier effective treatment could reduce this burden up to 48%.

How?
Reducing the risk of comorbidities means fewer hospitalizations, less medication costs, as well as improved mental health, increased productivity and better long-term health for over 100 million people living with psoriasis and psoriatic arthritis.

The message is clear: psoriasis and psoriatic arthritis are much more than skin and joint symptoms. They cost billions in healthcare and productivity losses and place a substantial burden on societies and economies.

A special thanks to Raquel Vaz, Scientific Project Lead at IFPA and co-author of the study, whose hard work helped bring this important evidence to light.

📖 Read the full article to explore the hidden cost of psoriatic disease and why earlier intervention matters. Link is in the first comment 👇